Sigpride MP 2mg/500mg/15mg Tablet SR
Marketer
Sigmus Biotech Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sigpride MP 2mg/500mg/15mg Tablet SR
Diabetic patients may find blood sugar management improved with the use of GlycoBalance SR tablets (2mg/500mg/15mg). This triple-action formulation, used in conjunction with diet and exercise, assists in better insulin utilization and consequently reduces blood glucose in adults with type 2 diabetes. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling the dose. Excessive dosage can cause hypoglycemia. Concurrent use with other diabetes medications, alcohol consumption, or meal skipping raises the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, increased bone fracture risk, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before commencing treatment. This is equally important for pregnant or nursing individuals. Kidney function testing will be performed prior to commencing treatment. Limiting alcohol intake is advised to mitigate potential side effects.
Primary Ingredients of Sigpride MP 2mg/500mg/15mg Tablet SR
No text was provided to rewrite.
Uses of Sigpride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sigpride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sigpride MP 2mg/500mg/15mg Extended-Release tablet should be taken with a meal.
Common Side effects of Sigpride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sigpride MP 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Sigpride MP 2mg/500mg/15mg Extended-Release tablet with food.
How Sigpride MP 2mg/500mg/15mg Tablet SR works:
Sigpride MP SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone to manage blood sugar. This triple-drug approach offers superior glycemic control when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sigpride MP 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Sigpride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Consult your physician for guidance.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sigpride MP tablet (2mg/500mg/15mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Sigpride MP 2mg/500mg/15mg SR tablets to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Sigpride MP 2mg/500mg/15mg SR tablets are contraindicated. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with hepatic impairment should use Sigpride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Sigpride MP 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Sigpride MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Sigpride MP 2mg/500mg/15mg Tablet SR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sigpride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently